Cargando…

Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease

Detalles Bibliográficos
Autores principales:	Jones, Harrison N., Fernandes, Samuela, Hannah, William B., Kansagra, Sujay, Raynor, Eileen M., Kishnani, Priya S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026278/ https://www.ncbi.nlm.nih.gov/pubmed/32090020 http://dx.doi.org/10.1016/j.ymgmr.2020.100574

Ejemplares similares

Long term outcome and clinical experience on immune tolerance induction therapies in infantile Pompe disease
por: Austin, Stephanie, et al.
Publicado: (2013)

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
por: Bali, Deeksha S., et al.
Publicado: (2015)

Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020)

The Outcome of Infantile Onset Pompe Disease in South of Iran
por: Moravej, Hossein, et al.
Publicado: (2016)

The infantile-onset form of Pompe disease: an autopsy diagnosis
por: dos Santos, Otávio César Cruz, et al.
Publicado: (2015)

Atypical Infantile-onset Pompe Disease with Hypertrophic Cardiomyopathy
por: Quan, Jun-Jun, et al.
Publicado: (2017)

A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted immunomodulation
por: Curelaru, Shiri, et al.
Publicado: (2022)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

Endomyocardial biopsy. Do it whenever you need it!()
por: de Sousa, Lídia
Publicado: (2020)

Immune tolerance strategies in siblings with infantile Pompe disease — Advantages for a preemptive approach to high-sustained antibody titers
por: Stenger, Elizabeth O., et al.
Publicado: (2015)

A General Introduction to Machine Learning (whenever possible with a twist towards accelerators)
por: Adelmann, Andreas
Publicado: (2022)

A General Introduction to Machine Learning (whenever possible with a twist towards accelerators)
por: Adelmann, Andreas
Publicado: (2022)

Quantitative whole‐body magnetic resonance imaging in children with Pompe disease: Clinical tools to evaluate severity of muscle disease
por: Fernandes, Samuela A., et al.
Publicado: (2020)

A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease
por: Gupta, Punita, et al.
Publicado: (2020)

Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy
por: Desai, Ankit K., et al.
Publicado: (2019)

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
por: Prater, Sean N, et al.
Publicado: (2013)

Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
por: Jackson, David G., et al.
Publicado: (2023)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Infantile onset Pompe disease presenting with non-immune hydrops fetalis
por: Lee, Kristen, et al.
Publicado: (2019)

Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes
por: Chen, Yi-Hua, et al.
Publicado: (2023)

Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort
por: Desai, Ankit K., et al.
Publicado: (2020)

“Time Slows Down Whenever You Are Around” for Women but Not for Men
por: Arantes, Joana, et al.
Publicado: (2021)

CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
por: Berrier, Kathryn L., et al.
Publicado: (2015)

New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside
por: Korlimarla, Aditi, et al.
Publicado: (2021)

The phenotype, genotype, and outcome of infantile-onset Pompe disease in 18 Saudi patients
por: Al-Hassnan, Zuhair N., et al.
Publicado: (2018)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020)

Infantile Pompe disease with intrauterine onset: a case report and literature review
por: Xi, Hongmin, et al.
Publicado: (2022)

Pompe disease- experience from South India
por: Lingappa, Lokesh, et al.
Publicado: (2013)

Behavioral, social and school functioning in children with Pompe disease
por: Korlimarla, Aditi, et al.
Publicado: (2020)

Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease
por: Hwang, Hsuen-En, et al.
Publicado: (2017)

Infantile-onset Pompe disease with neonatal debut: A case report and literature review
por: Martínez, Miriam, et al.
Publicado: (2017)

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand
por: Ngiwsara, Lukana, et al.
Publicado: (2019)

Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
por: Hsueh, Chien-Yu, et al.
Publicado: (2021)

Infantile‐onset Pompe disease with neutropenia: Treatment decisions in the face of a unique phenotype
por: Riedy, Mary, et al.
Publicado: (2022)

The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients
por: Feeney, Erin J, et al.
Publicado: (2014)

Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study
por: Dimachkie, Mazen M., et al.
Publicado: (2023)

Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: de las Heras, Javier, et al.
Publicado: (2021)

Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment
por: Senarathne, Udara Dilrukshi, et al.
Publicado: (2022)

Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations
por: Starosta, Rodrigo Tzovenos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ajc878ad0svdc0ncbr0fug5m9